Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions

被引：43

作者：

Marzolini, Catia ^{[1
,2
,3
,4
,5
]}

Kuritzkes, Daniel R. ^{[6
]}

Marra, Fiona ^{[7
,8
]}

Boyle, Alison ^{[7
,8
]}

Gibbons, Sara ^{[9
]}

Flexner, Charles ^{[10
,11
]}

Pozniak, Anton ^{[12
,13
]}

Boffito, Marta ^{[14
]}

Waters, Laura ^{[15
]}

Burger, David ^{[16
,17
]}

Back, David ^{[9
]}

Khoo, Saye ^{[9
]}

机构：

[1] Univ Hosp Basel, Div Infect Dis, Basel, Switzerland

[2] Univ Hosp Basel, Hosp Epidemiol, Dept Med, Basel, Switzerland

[3] Univ Hosp Basel, Hosp Epidemiol, Dept Clin Res, Basel, Switzerland

[4] Univ Basel, Basel, Switzerland

[5] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England

[6] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA

[7] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England

[8] NHS Greater Glasgow & Clyde, Dept Pharm, Glasgow, Lanark, Scotland

[9] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England

[10] Johns Hopkins Univ, Sch Med, Div Clin Pharmacol & Infect Dis, Baltimore, MD USA

[11] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA

[12] Chelsea & Westminster Hosp NHS Fdn Trust, London, England

[13] London Sch Hyg & Trop Med, London, England

[14] Chelsea & Westminster Hosp NHS Fdn Trust, London, England

[15] Cent & North West London, NHS Fdn Trust, Mortimer Market Ctr, London, England

[16] Radboud Univ Nijmegen, Dept Pharm, Med Ctr, Nijmegen, Netherlands

[17] Global DDI Solut, Utrecht, Netherlands

来源：

ANNALS OF INTERNAL MEDICINE | 2022年 / 175卷 / 05期

关键词：

THERAPY;

D O I：

10.7326/M22-0281

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：744 / +

页数：4

共 9 条

[1]

[Anonymous], 2022, COVID 19 DRUG INT

[2] Twenty years of boosting antiretroviral agents: where are we today? [J].

Boffito, Marta ;

Back, David ;

Gatell, Jose M. .

AIDS, 2015, 29 (17) :2229-2233

[3] Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers [J].

Ding, R ;

Tayrouz, Y ;

Riedel, KD ;

Burhenne, J ;

Weiss, J ;

Mikus, G ;

Haefeli, WE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (01) :73-84

[4] 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [J].

Ibanez, Borja ;

James, Stefan ;

Agewall, Stefan ;

Antunes, Manuel J. ;

Bucciarelli-Ducci, Chiara ;

Bueno, Hector ;

Caforio, Alida L. P. ;

Crea, Filippo ;

Goudevenos, John A. ;

Halvorsen, Sigrun ;

Hindricks, Gerhard ;

Kastrati, Adnan ;

Lenzen, Mattie J. ;

Prescott, Eva ;

Roffi, Marco ;

Valgimigli, Marco ;

Varenhorst, Christoph ;

Vranckx, Pascal ;

Widimsky, Petr .

KARDIOLOGIA POLSKA, 2018, 76 (02) :229-313

[5] Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites [J].

Marsousi, Niloufar ;

Daali, Youssef ;

Fontana, Pierre ;

Reny, Jean-Luc ;

Ancrenaz-Sirot, Virginie ;

Calmy, Alexandra ;

Rudaz, Serge ;

Desmeules, Jules Alexandre ;

Samer, Caroline Flora .

CLINICAL PHARMACOKINETICS, 2018, 57 (10) :1347-1354

[6] Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications [J].

Marzolini, Catia ;

Gibbons, Sara ;

Khoo, Saye ;

Back, David .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (07) :1755-1758

[7]

NIH, 2022, COVID 19 TREATM GUID

[8] Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect [J].

Stader, Felix ;

Khoo, Saye ;

Stoeckle, Marcel ;

Back, David ;

Hirsch, Hans H. ;

Battegay, Manuel ;

Marzolini, Catia .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (10) :3084-3086

[9]

Stader F, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00717-18, 10.1128/aac.00717-18]

← 1 →